Norway· NO-ID_10486146-F3E7-4DAE-83AA-210877DA17C1
Tevimbra
A tislelizumab product containing tislelizumab, registered in Norway by BeOne Medicines Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tislelizumab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FF09 (tislelizumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Tislelizumab · ATC L01FF09
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of tislelizumab costs, country by country.
Normalised to the WHO defined daily dose (9.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tislelizumab · price per daily dose (9.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$204.40
The record
At a glance
FEST (Norway)- Active substance
- Tislelizumab
- Manufacturer
- BeOne Medicines Ireland Limited
- Country
- Norway (NO)
- ATC code
- L01FF09
- ATC class
- Tislelizumab
- Defined daily dose
- 9.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_10486146-F3E7-4DAE-83AA-210877DA17C1
- no_varenummer40126310NOK 25027.7
- gtin8720598340235
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tislelizumab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTevimbra 100 mgBeOne Medicines Ireland
- CzechiaTEVIMBRABeOne Medicines Ireland Limited, Dublin
- FinlandTevimbraBeOne Medicines Ireland Limited
- IrelandTevimbra 100 mg concentrate for solution for infusionBeiGene Ireland Limited
- IcelandTevimbraBeigene Ireland Limited
- PolandTizveniBeiGene Ireland Ltd.
- SwedenTevimbra 100 mg Koncentrat till infusionsvätska, lösningBeOne Medicines Ireland Limited
- United StatesTEVIMBRABeOne Medicines USA, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Iceland · Tevimbra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/825f966c-4c4d-417e-8b53-bf5d4f38a071 GET /v1/drugs/825f966c-4c4d-417e-8b53-bf5d4f38a071?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Tislelizumab",
"merkevare_id": "ID_10486146-F3E7-4DAE-83AA-210877DA17C1",
"name_form_strength": "Tevimbra kons til inf oppl 100 mg",
"prescription_group": "C"
}See everything about tislelizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.